Chest Computed Tomography Severity Score to Predict Adverse Outcomes of Patients with COVID-19
- Author:
Somayeh HAJIAHMADI
1
;
Azin SHAYGANFAR
;
Mohsen JANGHORBANI
;
Mahsa Masjedi ESFAHANI
;
Mehdi MAHNAM
;
Nagar BAKHTIARVAND
;
Ramin SAMI
;
Nilufar KHADEMI
;
Mehrnegar DEHGHANI
Author Information
- Publication Type:Original Article
- From:Infection and Chemotherapy 2021;53(2):308-318
- CountryRepublic of Korea
- Language:English
-
Abstract:
Background:The novel coronavirus disease 2019 (COVID-19) continues to wreak havoc worldwide. This study assessed the ability of chest computed tomography (CT) severity score (CSS) to predict intensive care unit (ICU) admission and mortality in patients with COVID-19 pneumonia.
Materials and Methods:A total of 192 consecutive patients with COVID-19 pneumonia aged more than 20 years and typical CT findings and reverse-transcription polymerase chain reaction positive admitted in a tertiary hospital were included. Clinical symptoms at admission and short-term outcome were obtained. A semi-quantitative scoring system was used to evaluate the parenchymal involvement. The association between CSS, disease severity, and outcomes were evaluated. Prediction of CSS was assessed with the area under the receiver-operating characteristic (ROC) curves.
Results:The incidence of admission to ICU was 22.8% in men and 14.1% in women. CSS was related to ICU admission and mortality. Areas under the ROC curves were 0.764 for total CSS.Using a stepwise binary logistic regression model, gender, age, oxygen saturation, and CSS had a significant independent relationship with ICU admission and death. Patients with CSS ≥12.5 had about four-time risk of ICU admission and death (odds ratio 1.66, 95% confidence interval 1.66 – 9.25). The multivariate regression analysis showed the superiority of CSS over other clinical information and co-morbidities.
Conclusion:CSS was a strong predictor of progression to ICU admission and death and there was a substantial role of non-contrast chest CT imaging in the presence of typical features for COVID-19 pneumonia as a reliable predictor of clinical severity and patient’s outcome.
